Ioannis Boukovinas

7.6k total citations
84 papers, 1.8k citations indexed

About

Ioannis Boukovinas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ioannis Boukovinas has authored 84 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 45 papers in Pulmonary and Respiratory Medicine and 23 papers in Cancer Research. Recurrent topics in Ioannis Boukovinas's work include Colorectal Cancer Treatments and Studies (29 papers), Lung Cancer Treatments and Mutations (21 papers) and Gastric Cancer Management and Outcomes (16 papers). Ioannis Boukovinas is often cited by papers focused on Colorectal Cancer Treatments and Studies (29 papers), Lung Cancer Treatments and Mutations (21 papers) and Gastric Cancer Management and Outcomes (16 papers). Ioannis Boukovinas collaborates with scholars based in Greece, United States and United Kingdom. Ioannis Boukovinas's co-authors include Vassilis Georgoulias, Αthanassios Kyrgidis, Stefanos Triaridis, C. Andreadis, Georgios Koloutsos, Konstantinos Vahtsevanos, D. Mavroudis, John Souglakos, Panagiotis Paraskevopoulos and Konstantinos Zervas and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ioannis Boukovinas

77 papers receiving 1.8k citations

Peers

Countries citing papers authored by Ioannis Boukovinas

Since Specialization

Citations

This map shows the geographic impact of Ioannis Boukovinas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioannis Boukovinas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioannis Boukovinas more than expected).

Fields of papers citing papers by Ioannis Boukovinas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ioannis Boukovinas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioannis Boukovinas. The network helps show where Ioannis Boukovinas may publish in the future.

Co-authorship network of co-authors of Ioannis Boukovinas

This figure shows the co-authorship network connecting the top 25 collaborators of Ioannis Boukovinas. A scholar is included among the top collaborators of Ioannis Boukovinas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioannis Boukovinas. Ioannis Boukovinas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ALARM” study 2024 ·Cancer Medicine ·Sofia Agelaki, Ioannis Boukovinas, Ilias Athanasiadis, Georgios Trimis, Yannis Dimitriadis, (unknown), (unknown), (unknown), Goran Benčina, (unknown)	6
2	Evaluation of the attributable fraction and burden of HPV-related oropharyngeal cancers in Greece—the ORPHEAS study 2024 ·ESMO Open ·A. Psyrri, Georgios Psychogios, Efthymios Kyrodimos, J. Constantinidis, Sofia Agelaki, Ioannis Boukovinas, (unknown), (unknown), Aris Spathis, Panagiota Economopoulou, (unknown), Yannis Dimitriadis, (unknown), (unknown), Georgios Trimis, (unknown), Ioannis G. Panayiotides	0
3	Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction 2023 ·Cancers ·Dimitrios C. Ziogas, Eirini Papadopoulou, Helen Gogas, Stratigoula Sakellariou, (unknown), (unknown), Dimitra Stefanou, (unknown), Ioannis Boukovinas, Dimitris Matthaios, Anna Koumarianou, (unknown), Michalis Liontos, Konstantinos Koutsoukos, (unknown), (unknown), (unknown), Georgios Tsaousis, George Nasioulas	1
4	RETRO-TAS, a Retrospective Observational Study of Trifluridine/Tipiracil in Chemorefractory Metastatic Colorectal Cancer 2023 ·Biomedicines ·Anna Koumarianou, (unknown), (unknown), (unknown), (unknown), George Papaxoinis, (unknown), Ioannis Boukovinas, (unknown), (unknown), (unknown), Epaminontas Samantas, (unknown), Nikolaos Androulakis, Georgia Vourli, (unknown), Michalis V. Karamouzis	1
5	Effective early diagnosis for NSCLC: an algorithm 2021 ·Expert Review of Respiratory Medicine ·Paul Zarogoulidis, Dimitris Matthaios, Christoforos Kosmıdis, Wolfgang Hohenforst‐Schmidt, Kosmas Tsakiridis, (unknown), Ioannis Boukovinas, (unknown), (unknown), Bojan Zarić, Nikolaos Courcoutsakis, (unknown), Haidong Huang, Chong Bai	2
6	Priority of PET-CT vs CT Thorax for EBUS-TBNA 22G vs 19G: Mesothorax Lymphadenopathy 2021 ·Journal of Cancer ·Paul Zarogoulidis, Haidong Huang, (unknown), Ning Wu, (unknown), Dimitris Petridis, Kosmas Tsakiridis, Dimitris Matthaios, Christoforos Kosmıdis, Wolfgang Hohenforst‐Schmidt, (unknown), Ioannis Boukovinas, Nikolaos Courcoutsakis, (unknown), Chrysanthi Sardeli, Chong Bai, (unknown)	4
7	Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC). 2019 ·Journal of Clinical Oncology ·Timothy Iveson, Alberto F. Sobrero, Takayuki Yoshino, (unknown), Fang‐Shu Ou, (unknown), Qian Shi, Mark Saunders, Roberto Labianca, Takeharu Yamanaka, Ioannis Boukovinas, Niels Henrik Holländer, Valter Torri, Kentaro Yamazaki, Vassilis Georgoulias, Sara Lonardi, Andrea Harkin, Gerardo Rosati, James Paul	27
8	Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group 2017 ·British Journal of Cancer ·Dimitriοs Mavroudis, Emmanouil Saloustros, Ioannis Boukovinas, Pavlos Papakotoulas, Stylianos Kakolyris, Nikolaos Ziras, (unknown), Nikolaos Kentepozidis, George Fountzilas, George Rigas, Ioannis Varthalitis, K. Kalbakis, Sofia Agelaki, Dora Hatzidaki, (unknown)	8
9	Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG) 2016 ·Annals of Oncology ·Dimitriοs Mavroudis, Alexios Matikas, N. Malamos, Pavlos Papakotoulas, Stylianos Kakolyris, Ioannis Boukovinas, A. Athanasiadis, Nikolaos Kentepozidis, (unknown), (unknown), Emmanouil Saloustros, Vassilis Georgoulias	24
10	Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG) 2014 ·BMC Cancer ·Lambros Vamvakas, Alexios Matikas, Athanasios Karampeazis, Dora Hatzidaki, S. Kakolyris, (unknown), Ioannis Boukovinas, Aris Polyzos, Vassilis Georgoulias, John Souglakos	14
11	A multicenter phase I–II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancer 2013 ·The Breast ·(unknown), Ioannis Boukovinas, Nikolaos Xenidis, (unknown), Pavlos Papakotoulas, Eleni Politaki, Nikolaos Malamos, Aris Polyzos, S. Kakolyris, Vassilis Georgoulias, D. Mavroudis	9
12	Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG) 2011 ·Cancer Chemotherapy and Pharmacology ·Ioannis Boukovinas, Nikolaos Androulakis, Nikolaos Kentepozidis, Aris Polyzos, Pavlos Papakotoulas, Nikolaos Ziras, Αthanasios Kotsakis, N. Vardakis, Athanasios Karampeazis, (unknown), A. Kostakopoulos, C. Constantinides, George Samonis, Dimitris Mavroudis, Vassilis Georgoulias	4
13	FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG) 2009 ·Breast Cancer Research and Treatment ·(unknown), Nikolaos Malamos, Ioannis Boukovinas, (unknown), Nikolaos Ziras, Kostas Kalbakis, Stylianos Kakolyris, Kostas Syrigos, Pavlos Papakotoulas, Charalambos Kouroussis, (unknown), Lambros Vamvakas, (unknown), Athanasios Athanasiadis, Ioannis Varthalitis, Vassilis Georgoulias, Dimitris Mavroudis	34
14	Pooled Analysis of Elderly Patients with Non-small Cell Lung Cancer Treated with Front Line Docetaxel/Gemcitabine Regimen: The Hellenic Oncology Research Group Experience 2008 ·Journal of Thoracic Oncology ·Athanasios Pallis, Aris Polyzos, Ioannis Boukovinas, Athina Agelidou, (unknown), Xanthi Tsiafaki, M. Agelidou, (unknown), (unknown), S. Kakolyris, (unknown), Nikolaos Kentepozidis, (unknown), Nikolaos Androulakis, Sofia Agelaki, Vassilis Georgoulias	24
15	Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine 2008 ·British Journal of Cancer ·John Souglakos, Ioannis Boukovinas, Miquel Tarón, Pedro Méndez, D. Mavroudis, (unknown), Dora Hatzidaki, Anastasios Koutsopoulos, Efstathios N. Stathopoulos, Vassilis Georgoulias, Rafael Rosell	90
16	Distant forearm muscle metastasis from squamous cell lung carcinoma. 2008 ·PubMed ·Nikolaos Barbetakis, George Samanidis, Dimitrios Paliouras, (unknown), Ioannis Boukovinas, Christodoulos Tsilikas	1
17	Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group 2007 ·Annals of Oncology ·P. Kosmidis, Haralabos P. Kalofonos, C. Christodoulou, K. Syrigos, Thomas Makatsoris, D. Skarlos, (unknown), C. Nicolaides, Dimitrios Bafaloukos, Aristotelis Bamias, E. Samantas, Nikolaos I. Xiros, Ioannis Boukovinas, George Fountzilas, Meletios Α. Dimopoulos	46
18	Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group 2006 ·Annals of Oncology ·Ioannis Boukovinas, N. Androulakis, L. Vamvakas, Pavlos Papakotoulas, Nikolaos Ziras, Aristidis Polyzos, A. Kalykaki, (unknown), N. Xenidis, (unknown), Dimitriοs Mavroudis, V. Georgoulias	11
19	Novel genomic rearrangements in the BRCA1 gene detected in greek breast/ovarian cancer patients 2006 ·European Journal of Cancer ·(unknown), Irene Konstantopoulou, (unknown), Evangelia Razis, Ioannis Boukovinas, Nikolaos Xenidis, George Fountzilas, Drakoulis Yannoukakos	42
20	Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial 2004 ·Annals of Oncology ·John Souglakos, Konstantinos Syrigos, Anna Potamianou, Aristidis Polyzos, Ioannis Boukovinas, N. Androulakis, Ch. Kouroussis, N. Vardakis, (unknown), Αthanasios Kotsakis, Vassilis Georgoulias	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact